Is It Time to Sell Teva Pharmaceutical's Stock?
Teva Pharmaceutical is a selection for the real-money Inflation-Protected Income Growth portfolio. Like any investment, it needs to be reviewed from time to time to see whether it still deserves a spot in the portfolio. In the brief following video, portfolio manager Chuck Saletta reviews its valuation, balance sheet, and dividends and decides whether to hold on to the stock or let it go.
To follow the IPIG portfolio as buy and sell decisions are made, watch Chuck's article feed by clicking here. To join The Motley Fool's free discussion board dedicated to the IPIG portfolio, simply click here.
Investing doesn't have to be rocket science -- even if you're buying companies that make rockets
Millions of Americans have waited on the sidelines since the market meltdown in 2008 and 2009, too scared to invest and put their money at further risk. Yet those who've stayed out of the market have missed out on huge gains and put their financial futures in jeopardy. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal finance experts show you why investing is so important and what you need to do to get started. Click here to get your copy today -- it's absolutely free.
The article Is It Time to Sell Teva Pharmaceutical's Stock? originally appeared on Fool.com.Chuck Saletta owns shares of Teva Pharmaceutical Industries. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.